Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 21:5:274-279.
doi: 10.1016/j.bonr.2016.09.003. eCollection 2016 Dec.

Combined aerobic and resistance training improves bone health of female cancer survivors

Affiliations

Combined aerobic and resistance training improves bone health of female cancer survivors

Hawley C Almstedt et al. Bone Rep. .

Abstract

Introduction: Cancer pathogenesis and resulting treatment may lead to bone loss and poor skeletal health in survivorship. The purpose of this investigation was to evaluate the influence of 26 weeks of combined aerobic and resistance-training (CART) exercise on bone mineral density (BMD) in a multi-racial sample of female cancer survivors.

Methods: Twenty-six female cancer survivors volunteered to undergo CART for 1 h/day, 3 days/week, for 26 weeks. The Improving Physical Activity After Cancer Treatment (IMPAACT) Program involves supervised group exercise sessions including 20 min of cardiorespiratory training, 25 min of circuit-style resistance-training, and 15 min of abdominal exercises and stretching. BMD at the spine, hip, and whole body was assessed using dual-energy X-ray absorptiometry (DXA) before and after the intervention. Serum markers of bone metabolism (procollagen-type I N-terminal propeptide, P1NP, and C-terminal telopeptides, CTX) were measured at baseline, 13 weeks, and at study completion.

Results: Eighteen participants, with the average age of 63.0 ± 10.3 years, completed the program. Mean duration since completion of cancer treatment was 6.2 ± 10.6 years. Paired t-tests revealed significant improvements in BMD of the spine (0.971 ± 0.218 g/cm2 vs. 0.995 ± 0.218 g/cm2, p = 0.012), hip (0.860 ± 0.184 g/cm2 vs. 0.875 ± 0.191 g/cm2, p = 0.048), and whole body (1.002 ± 0.153 g/cm2 vs. 1.022 ± 0.159 g/cm2, p = 0.002). P1NP declined 22% at 13 weeks and 28% at 26 weeks in comparison to baseline (p < 0.01) while CTX showed a non-significant decrease of 8% and 18% respectively.

Conclusions: We report significant improvements in BMD at the spine, hip, and whole body for female cancer survivors who completed 26 weeks of CART. This investigation demonstrates the possible effectiveness of CART at improving bone health and reducing risk of osteoporosis for women who have completed cancer treatment. The IMPAACT Program appears to be a safe and feasible way for women to improve health after cancer treatment.

Keywords: BMD, bone mineral density; BTM, bone turnover marker; Bone mineral density; Bone turnover markers; CART, combined aerobic and resistance training; CTX, C-terminal telopeptides; Cancer-induced bone loss; DXA, dual-energy X-ray absorptiometry; FFQ, food frequency questionnaire; IMPAACT, improving physical activity after cancer treatment; NTX, N-telopeptide cross-linked collagen type I; Oncology; Osteoporosis; P1NP, procollagen-type I N-terminal propeptides.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Bone turnover markers.

References

    1. DeSantis C.E., Lin C.C., Mariotto A.B., Siegel R.L., Stein K.D., Kramer J.L., Alteri R., Robbins A.S., Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin. 2014;64:252–271. - PubMed
    1. Leach C.R., Weaver K.E., Aziz N.M., Alfano C.M., Bellizzi K.M., Kent E.E., Forsythe L.P., Rowland J.H. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J. Cancer Surviv. 2015;9:239–251. - PubMed
    1. Tarleton H.P., Ryan-Ibarra S., Induni M. Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009–2010. J. Cancer Surviv. 2014;8:448–459. - PubMed
    1. Weaver K.E., Foraker R.E., Alfano C.M., Rowland J.H., Arora N.K., Bellizzi K.M., Hamilton A.S., Oakley-Girvan I., Keel G., Aziz N.M. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J. Cancer Surviv. 2013;7:253–261. - PMC - PubMed
    1. Nishio K., Tanabe A., Maruoka R., Nakamura K., Takai M., Sekijima T., Tunetoh S., Terai Y., Ohmichi M. Bone mineral loss induced by anticancer treatment for gynecological malignancies in premenopausal women. Endocr Connect. 2013;2:11–17. - PMC - PubMed

LinkOut - more resources